Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.

Journal of the American College of Cardiology - 19 Mar 2013

Kamstrup Pia R, Tybjærg-Hansen Anne, Nordestgaard Børge G

Abstract excerpt

OBJECTIVES: The study tested whether extreme lipoprotein(a) levels and/or corresponding LPA risk genotypes improve myocardial infarction (MI) and coronary heart disease (CHD) risk prediction beyond conventional risk factors. BACKGROUND: Elevated lipoprotein(a) levels cause MI and CHD. Levels are primarily determined by variation in the LPA gene. METHODS: We followed 8,720 Danish participants in a general...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Coronary Disease
Share to LPA gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Lipoprotein(a)

Share to Myocardial Infarction

Share to Prognosis

Share to Risk Assessment

Source

Identifiers

PMID: 23375930
DOI: 10.1016/j.jacc.2012.12.023

Genes

LPA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.PMID 23375930Read ↗

Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population.Semantic proximity Read ↗

Clinical Utility of Lipoprotein(a) and <i>LPA</i> Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular DiseaseSemantic proximity Read ↗

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.Semantic proximity Read ↗

Polygenic modulation of lipoprotein(a)-associated cardiovascular riskSemantic proximity Read ↗

Genetics and Pathophysiological Mechanisms of Lipoprotein(a)-Associated Cardiovascular Risk.Semantic proximity Read ↗

Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis.Semantic proximity Read ↗

A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohortSemantic proximity Read ↗

Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarctionSemantic proximity Read ↗

Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry.Semantic proximity Read ↗

Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.Semantic proximity Read ↗

Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events.Semantic proximity Read ↗

Lipoprotein(a) molar concentrations rather than genetic variants better predict coronary artery disease risk and severity in Han Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.